close

Fenwick Represents Natus Medical in Acquisition of CareFusion’s Neurodiagnostic Business for $58M

April 23, 2012

Fenwick & West LLP represented Natus Medical Incorporated (NASDAQ: BABY), a leading provider of health care screening, diagnostic and treatment products, in its agreement to purchase the CareFusion Nicolet business for a cash purchase price of approximately $58 million. The acquisition is expected to close in July 2012, subject to customary closing conditions.

The Fenwick transaction team included corporate attorneys Dan Winnike, Kris Withrow, Ken Essen, Aaron Hou, and Gaurav Sud; executive compensation and employee benefits attorneys Gerald Audant and Mona Clee; intellectual property attorneys Mark Ostrau and Stefano Quintini; and tax attorneys Ron Schrotenboer and William Skinner.

More information about the transaction is available from the official Natus statement. ​